RAY notified by Nasdaq on $1.00 bid rule; deadline April 13, 2026
Rhea-AI Filing Summary
Raytech Holding Limited received a Nasdaq notice that its ordinary shares failed the Minimum Bid Price Rule after trading below $1.00 for 30 consecutive business days. The shares continue to trade on Nasdaq under “RAY.”
Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days, until April 13, 2026, to regain compliance. Compliance will be restored if the closing bid price reaches at least $1.00 for a minimum of 10 consecutive business days during this period.
If compliance is not achieved by April 13, 2026, the Company may qualify for an additional 180-day grace period by meeting all other initial listing standards for the Nasdaq Capital Market (except the bid price) and by notifying Nasdaq of its plan to cure the deficiency, which may include a reverse stock split.
Positive
- None.
Negative
- None.
Insights
Nasdaq deficiency notice sets a clear 180-day cure path.
The notice reflects a technical listing deficiency: RAY’s bid stayed below $1.00 for 30 straight business days. Trading remains on Nasdaq, so liquidity access is unchanged for now. The primary cure is achieving a closing bid of at least $1.00 for 10 consecutive business days within the 180-day window ending April 13, 2026.
If unmet, a second 180-day period may be available, provided the company meets other initial listing standards and submits a written plan. The filing notes a potential reverse stock split as a cure mechanism. Actual outcomes hinge on market pricing or corporate actions; no timing beyond the stated windows is indicated.